Table 2.
Characteristic | No. of Patients (n = 172) | Percentage |
---|---|---|
Age, yr | ||
Median (range) | 60.7 (19.2–85.6) | |
Mean ± SD | 60 ± 14.6 | |
Sex | ||
Female | 69 | 40.0 |
Male | 103 | 60.0 |
Disease classification | ||
Lymphoma* | 100 | 58.0 |
Non-Hodgkin lymphoma | 87 | |
Hodgkin lymphoma | 13 | |
Acute leukemia | 27 | 16.0 |
AML† | 23 | |
ALL | 4 | |
Chronic leukemia | 27 | 16.0 |
CML | 7 | |
CLL | 20 | |
Multiple myeloma‡ | 18 | 10.0 |
Treatment | ||
Chemotherapy 3 mo before procedure | 122 | 71.0 |
Proceduralist | ||
Pulmonologist | 134 | 77.9 |
Thoracic surgeons | 21 | 12.2 |
Interventional radiologists | 17 | 9.9 |
Location of procedure | ||
Outpatient | 69 | 40.1 |
Inpatient | 103 | 59.9 |
Definition of abbreviations: ALL = acute lymphocytic leukemia; AML = acute myelogenous leukemia; CLL = chronic lymphocytic leukemia; CML = chronic myelogenous leukemia.
Includes Waldenström macroglobulinemia and Castleman disease.
Includes myelodysplastic syndrome.
Includes amyloidosis with plasma cell dyscrasia and plasma cell lymphoma.